glp-1 hub podcast Studio GLP-1 Hub: Support, Community, and
Description
At the time of the study in early 2024, about 0.5% of the adult population in the US was using GLP - 1 therapies
Its no secret that GLP-1 medications like Ozempic, Wegovy, and Saxenda have become increasingly popular for weight loss
Journal of Neuroscience Research 72 (5): 603-12
Other Reported Vision Issues From Wegovy In addition to NAION, people with diabetes or cardiovascular risk factors who take Wegovy may still be at risk for other common eye conditions such as diabetic retinopathy, macular edema, or ocular migraines (although these conditions can occur in people not taking Wegovy)
